mirvetuximab
immunogen
['mirvetuximab', 'immunogen']
we had a great time at #asco22 showcasing additional safety and efficacy data from our #mirvetuximab program and reviewing research in 100+ presentations in our therapeutic areas of interest. next stop, #eha22 in vienna! 
We exist to interrupt the progress of cancer so cancer can't interrupt the lives of our patients. #TargetABetterNow

Policy: https://t.co/MLtPQiuFPo